Centaurus Financial, Inc. Rubius Therapeutics, Inc. Transaction History

Centaurus Financial, Inc.

  • $1.4 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022
SELL
$9.68 - $17.74 $121,000 - $221,749
-12,500 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$17.6 - $25.91 $26,400 - $38,865
-1,500 Reduced 10.71%
12,500 $224,000
Q1 2021

Apr 30, 2021
SELL
$8.02 - $32.01 $12,030 - $48,015
-1,500 Reduced 9.68%
14,000 $371,000
Q4 2020

Jan 25, 2021
BUY
$4.23 - $8.73 $65,565 - $135,315
15,500 New
15,500 $118,000

Others Institutions Holding RUBY

# of Institutions
2
Shares Held
325
Call Options Held
0
Put Options Held
0
View Full List

About Rubius Therapeutics, Inc.

RUBY Quotes by TradingView
  • Ticker RUBY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,357,000
  • Description
  • Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...
More about RUBY
Track This Portfolio

Track Centaurus Financial, Inc. Portfolio

Follow Centaurus Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email